In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Intraoperative complications are similar whether staging of endometrial cancer is performed laparoscopically or by laparotomy, but laparoscopy has the advantage when it comes…
NEW YORK (Reuters Health) – Methylprednisolone does not improve outcomes in newborns undergoing cardiac surgery, and it may increase the risk of infection in some of those infants,…
NEW YORK (Reuters Health) – N-acetylcysteine is increasingly used to prevent contrast-induced nephropathy (CIN) but it is not effective, according to a paper in JACC: Cardiovascular Interventions for…
NEW YORK (Reuters Health) – Whether suspected intrauterine growth restriction (IUGR) at term is managed by induction of labor or by expectant monitoring, the degree of neonatal morbidity…
NEW YORK (Reuters Health) – For nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA), linezolid is more effective and better tolerated than the gold standard vancomycin, according to…
NEW YORK (Reuters Health) – Percutaneous placement of a sirolimus-eluting stent (SES) is a safe and effective way to address either bare-metal (BMS) or drug-eluting (DES) in-stent restenosis,…
NEW YORK (Reuters Health) – Pregabalin (Lyrica; Pfizer Inc) may help patients with fibromyalgia get a better night’s sleep, in addition to easing their pain, suggest results of…
Despite the importance of sleep for recovery, hospital noise may put patients at risk for sleep loss and its associated negative effects. Objectively measured hospital noise can range…
NEW YORK (Reuters Health) – Patients on beta-blockers who undergo surgery are nearly twice as likely to experience adverse events in the following months if beta-blockers are discontinued,…
